Quantitative analysis of islet glutamic acid decarboxylase p64 autoantibodies in insulin-dependent diabetes mellitus

Heike Bärmeier, Jarl Ahlmén, Mono Landin-Olsson, Ray V. Rajotte, Göran Sundkvist, Garth Warnock, Åke Lernmark

Research output: Contribution to journalArticlepeer-review

Abstract

Autoantibodies against the βcell Mr 64,000 protein (p64), recently identified as an isoform of glutamic acid decarboxylase (GAD), are prevalent in patients with insulin-dependent diabetes mellitus (IDDM). Dog islets were found to represent an abundant source of native p64 allowing the study of antigen-antibody interactions in IDDM. A quantitative, standardized assay for p64 antibodies based on dog islets was developed and evaluated. Utilizing dog and human islets the p64 antibodies were detected in 17/19 (89%) new onset 15-32-year-old patients, compared to 15/19 (79%) in a rat islet assay. ICA were detected in 15/19 (79%) patients and correlated with the presence of p64 antibodies (rs=0.59, P < 0.004) but not with age at onset, sex, or C-peptide levels. Sensitivity therefore is improved with the dog islet p64 antibody assay which will allow future studies requiring native p64 antigen in larger quantities are possible based on our findings.

Original languageEnglish
Pages (from-to)187-196
JournalAutoimmunity
Volume13
Issue number3
DOIs
Publication statusPublished - 1992 Jan 1
Externally publishedYes

Subject classification (UKÄ)

  • Endocrinology and Diabetes

Free keywords

  • Autoantibodies
  • Autoantigen
  • Dog islets
  • Immunoprecipitation
  • Islet cell antibodies

Fingerprint

Dive into the research topics of 'Quantitative analysis of islet glutamic acid decarboxylase p64 autoantibodies in insulin-dependent diabetes mellitus'. Together they form a unique fingerprint.

Cite this